Table 2—

Changes in QoL measures from baseline to last follow-up according to the presence/development of ED

QoL measuresED
No
At baseline
Incident
BaselineChange*Effect sizeBaselineChange*Effect sizeBaselineChange*Effect size
PF84.7 ± 17.70.3 ± 16.70.0175.1 ± 23.3−3.3 ± 20.1−0.1676.3 ± 23.3−3.5 ± 24.1−0.16
RP77.4 ± 34.6−0.8 ± 39.2−0.0258.0 ± 43.1−0.7 ± 40.6−0.0260.5 ± 41.0−1.6 ± 43.9−0.04
BP78.0 ± 23.5−0.2 ± 25.9−0.0867.1 ± 25.6−1.2 ± 25.7−0.0570.4 ± 26.10.4 ± 29.60.01
GH61.6 ± 18.00.5 ± 16.40.0251.7 ± 20.2−1.3 ± 16.7−0.0655.4 ± 19.6−2.2 ± 20.2−0.11
VT67.2 ± 18.10.1 ± 16.50.00556.7 ± 20.0−0.9 ± 17.6−0.0459.5 ± 18.8−2.3 ± 18.5−0.12
SF78.8 ± 21.81.1 ± 24.10.0567.0 ± 26.12.0 ± 24.70.0872.5 ± 23.1−1.2 ± 28.0−0.05
RE78.1 ± 34.62.5 ± 39.80.0659.2 ± 43.22.1 ± 40.70.0562.5 ± 40.8−2.0 ± 48.4−0.05
MH73.5 ± 18.30.5 ± 16.10.0265.0 ± 21.31.0 ± 16.90.0568.1 ± 17.3−2.2 ± 18.6−0.11
PCS49.3 ± 7.6−0.2 ± 7.3−0.0244.7 ± 8.6−1.0 ± 7.3−0.1246.8 ± 8.5−1.4 ± 9.3−0.16
MCS49.0 ± 10.00.8 ± 9.40.0744.6 ± 11.61.0 ± 9.90.1046.3 ± 9.5−1.1 ± 10.6−0.10
SLQ84.3 ± 16.40.7 ± 14.70.0362.1 ± 23.2−0.3 ± 23.1−0.0175.5 ± 20.9−8.5 ± 20.2−0.39
CES-D16.3 ± 9.0−0.8 ± 8.0−0.0919.9 ± 10.00.6 ± 9.10.0718.7 ± 8.91.0 ± 9.60.10
  • Statistically significant changes from baseline (P ≤ 0.05) are in boldface.

  • *

    * Positive change indicates improvement for SF-36 dimensions and Sexual Life Questionnaire (SLQ) and deterioration for CES-D score; negative change indicates deterioration for SF-36 dimensions and SLQ and improvement for CES-D score. BP, bodily pain; GH, general health perception; MCS, mental component summary; MH, mental health; PCS, physical component summary; PF, physical functioning; RE, role limitations caused by emotional health problems; RP, role limitations caused by physical health problems; SF, social functioning; VT, vitality.